Found: 30
Select item for more details and to access through your institution.
Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein–Barr Virus in MS Development: A Presymptomatic Case–Control Study.
- Published in:
- Annals of Neurology, 2024, v. 96, n. 2, p. 302, doi. 10.1002/ana.27009
- By:
- Publication type:
- Article
Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis.
- Published in:
- Brain: A Journal of Neurology, 2024, v. 147, n. 1, p. 177, doi. 10.1093/brain/awad374
- By:
- Publication type:
- Article
Immune response to SARS-CoV2 mRNA vaccination in multiple sclerosis patients after rituximab treatment interruption.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1219560
- By:
- Publication type:
- Article
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2022, v. 79, n. 11, p. 1105, doi. 10.1001/jamaneurol.2022.2887
- By:
- Publication type:
- Article
Free vitamin D<sub>3</sub> index and vitamin D‐binding protein in multiple sclerosis: A presymptomatic case–control study.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 8, p. 2335, doi. 10.1111/ene.15407
- By:
- Publication type:
- Article
Axonal injury in asymptomatic individuals preceding onset of multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2022, v. 9, n. 6, p. 882, doi. 10.1002/acn3.51568
- By:
- Publication type:
- Article
Incidence and Prevalence of Multiple Sclerosis in Malmö, Southern Sweden.
- Published in:
- Multiple Sclerosis International, 2022, p. 1, doi. 10.1155/2022/5464370
- By:
- Publication type:
- Article
Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis.
- Published in:
- Journal of Neurology, 2021, v. 268, n. 6, p. 2161, doi. 10.1007/s00415-021-10399-8
- By:
- Publication type:
- Article
Epstein–Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosis.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 2, p. 579, doi. 10.1111/ene.14597
- By:
- Publication type:
- Article
Leptin levels are associated with multiple sclerosis risk.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 1, p. 19, doi. 10.1177/1352458520905033
- By:
- Publication type:
- Article
Response to 'Mendelian randomization analysis does not support a role for leptin in multiple sclerosis'.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Comparative effectiveness of dimethyl fumarate as the initial and secondary treatment for MS.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 12, p. 1532, doi. 10.1177/1352458519866600
- By:
- Publication type:
- Article
Intrathecal immunoreactivity in people with or without previous infectious mononucleosis.
- Published in:
- Acta Neurologica Scandinavica, 2020, v. 142, n. 2, p. 161, doi. 10.1111/ane.13280
- By:
- Publication type:
- Article
High serum concentration of vitamin D may protect against multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 4, p. 1, doi. 10.1177/2055217319892291
- By:
- Publication type:
- Article
Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trial.
- Published in:
- Acta Neurologica Scandinavica, 2019, v. 139, n. 5, p. 462, doi. 10.1111/ane.13078
- By:
- Publication type:
- Article
Inflammatory activity and vitamin D levels in an MS population treated with rituximab.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 1, p. 1, doi. 10.1177/2055217319826598
- By:
- Publication type:
- Article
Immunological profile in cerebrospinal fluid of patients with multiple sclerosis after treatment switch to rituximab and compared with healthy controls.
- Published in:
- PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0192516
- By:
- Publication type:
- Article
The impact of adjusted work conditions and disease-modifying drugs on work ability in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 8, p. 1137, doi. 10.1177/1352458516671818
- By:
- Publication type:
- Article
Effect of high-dose vitamin D<sub>3</sub> supplementation on antibody responses against Epstein–Barr virus in relapsing-remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 3, p. 395, doi. 10.1177/1352458516654310
- By:
- Publication type:
- Article
The interaction between smoking and Epstein-Barr virus as multiple sclerosis risk factors may depend on age.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 6, p. 747, doi. 10.1177/1352458513507820
- By:
- Publication type:
- Article
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 1, p. 43, doi. 10.1177/1352458513490544
- By:
- Publication type:
- Article
Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 12, p. 1587, doi. 10.1177/1352458513483888
- By:
- Publication type:
- Article
Smoking as a risk factor for multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 8, p. 1022, doi. 10.1177/1352458512470862
- By:
- Publication type:
- Article
Vitamin A and systemic inflammation as protective factors in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 8, p. 1046, doi. 10.1177/1352458512472752
- By:
- Publication type:
- Article
Timing of cigarette smoking as a risk factor for multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2013, v. 6, n. 3, p. 205, doi. 10.1177/1756285613479427
- By:
- Publication type:
- Article
Translations in International Organisations: Is the Non-native Character of Target Language Texts Inevitable?
- Published in:
- Translation Quarterly, 2011, n. 61, p. 68
- By:
- Publication type:
- Article
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.
- Published in:
- Annals of Neurology, 2011, v. 69, n. 1, p. 83, doi. 10.1002/ana.22247
- By:
- Publication type:
- Article
Venous and cerebrospinal fluid flow in multiple sclerosis: A case-control study.
- Published in:
- Annals of Neurology, 2010, v. 68, n. 2, p. 255, doi. 10.1002/ana.22132
- By:
- Publication type:
- Article
Neurofilament light as a prognostic marker in multiple sclerosis.
- Published in:
- Multiple Sclerosis (13524585), 2010, v. 16, n. 3, p. 287, doi. 10.1177/1352458509359725
- By:
- Publication type:
- Article
Book review.
- Published in:
- 2005
- By:
- Publication type:
- Book Review